Evolution Wealth Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-367
Closed -$10K 380
2021
Q3
$10K Sell
367
-551
-60% -$14.5K ﹤0.01% 397
2021
Q2
$26K Buy
918
+213
+30% +$6.32K 0.01% 275
2021
Q1
$24K Buy
705
+55
+8% +$2.1K 0.01% 269
2020
Q4
$22K Sell
650
-312
-32% -$11.4K 0.01% 254
2020
Q3
$31K Sell
962
-87
-8% -$2.5K 0.01% 227
2020
Q2
$29K Hold
1,049
0.01% 177
2020
Q1
$17K Sell
1,049
-48
-4% -$1.14K 0.01% 161
2019
Q4
$26K Buy
1,097
+989
+916% +$20.1K 0.01% 202
2019
Q3
$2K Buy
+108
New +$2.09K ﹤0.01% 415

Other funds holding INSM

Evolution Wealth Advisors's INSM Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Insmed (INSM) in Q4 2021, closing a stake of 367 shares — an estimated $10K sold.

Evolution Wealth Advisors first reported a position in INSM in Q3 2019 and held it in 9 quarters. The position peaked at $31K in Q3 2020. 214 funds tracked by Wall St. Rank hold INSM as of Q4 2021.

  • Evolution Wealth Advisors reported no remaining Insmed position as of Q4 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 367 Insmed shares in Q4 2021, an estimated $10K.
  • Evolution Wealth Advisors first reported a position in Insmed in Q3 2019 and held it in 9 quarters.
  • Evolution Wealth Advisors's Insmed position peaked at $31K in Q3 2020.
  • 214 funds tracked by Wall St. Rank held Insmed as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.